Angels Partners logo
  • Find Angel Investors
    • Find Angel Investors in the US
    • Find Angel Investors in the UK
    • Find Angel Investors in Europe
      Find Angel Investors in DenmarkFind Angel Investors in FinlandFind Angel Investors in FranceFind Angel Investors in GermanyFind Angel Investors in ItalyFind Angel Investors in NetherlandsFind Angel Investors in SwedenFind Angel Investors in Switzerland
    • Find Angel Investors in Canada
    • Find Angel Investors in Australia
  • Top VC Firms
    Top AI VC firmsTop BioTech VC firmsTop CleanTech VC firmsTop Cyber Security VC firmsTop E-commerce VC firmsTop HealthTech VC firmsTop FinTech VC firmsTop Food Industry VC firmsTop Robotics VC firmsTop SaaS VC firmsTop Transportation VC firms
  • Pricing
  • Products
    Investor CommunityInvestor DatabaseAutomationWarm IntrosFounder CommunityDocument SharingLegal Templates
  • FAQ
  • Blog
  • About
  • Sign up
  • Log in
Are you an

  • Entrepreneur
  • Investor
< Browse Firms
Logo Firm Jennison Associates
websitelinkedinfacebooktwittergoogle

Jennison Associates

map marker logo New York (NY) |  U.S.A.

Investor TypeFirm
IndustriesEducation • Healthcare (& Wellness) • Investment Management • Life Science
InvestingUnited States
Investment Range $36,000,000  -  $120,000,000

Investors who co-invest with Jennison Associates

Investors who are part of this firm

About The Fund

Jennison Associates is a prominent investment manager specializing in providing a variety of investment strategies to an extensive client base. As a wholly-owned subsidiary of Prudential Financial, Inc., Jennison has carved out a unique position in the industry since its inception in 1969. Operating out of their New York City base, with additional offices in Waltham, Massachusetts, they offer their services to a diverse group including charitable organizations, corporations, state and municipal government entities, insurance companies, other investment advisers, welfare plans, Taft-Hartley accounts, families, endowments, foundations, institutional clients, and private clients. Their investment offerings encompass client-focused equity, fixed income, and balanced portfolios, each carefully crafted by an experienced team of investment professionals. The investment philosophy at Jennison is deeply rooted in rigorous fundamental research and meticulous security selection, with each portfolio constructed from the bottom up, security by security. This approach underscores their dedication to delivering performance over benchmarks and peer groups across market cycles.With a minimum investment of $36 million and a maximum of $120 million, Jennison targets industries that include Education, Healthcare & Wellness, Investment Management, and Life Sciences among others. Their involvement in Thematic Equity also showcases their focus on sectors like Health Sciences, Utility Equity, Global Infrastructure, Global Natural Resources, Energy Infrastructure, Financial Services, Technology Equity, and Global Healthcare.Their proficient team, consisting of 86 investment professionals and a total workforce of 407 employees, manages assets worth $214 billion as of September 30, 2024. This extensive experience and financial clout fortify Jennison's capability to leverage long-term growth themes within the markets, such as their emphasis on AI technology as a secular growth narrative.Jennison's commitment to responsible investing is also emphasized through their sustainability initiatives that encompass integration, proxy voting, stewardship, corporate citizenship, and a comprehensive document center available for educational purposes.For individuals and organizations looking to navigate complex market environments, Jennison stands out as a beacon of investment expertise, intuitively aligning client objectives with global investment opportunities.

Jennison Associates's investments on record

Syndax Pharmaceuticals $80,000,000.00 Series C
Editas Medicine $120,000,000.00 Later stage VC
Allogene Therapeutics $120,000,000.00 Later stage VC
Ovid Therapeutics $75,000,000.00 Later stage VC
REGENXBIO $70,500,000.00 Later stage VC
Wave Life Sciences $66,000,000.00 Later stage VC
UNUM Therapeutics $65,000,000.00 Later stage VC
Dimension Therapeutics $65,000,000.00 Later stage VC
Natera $55,500,000.00 Later stage VC
Tweets by Jennison Associates

Similar Investment Firms

Similar Investor Gore Range Capital
Gore Range Capital
Similar Investor Mayo Clinic Ventures
Mayo Clinic Ventures
Similar Investor StartUp Health
StartUp Health
Similar Investor Odyssey Investment Partners, LLC
Odyssey Investment Partners, LLC
Similar Investor GenNx360 Capital Partners
GenNx360 Capital Partners
Similar Investor Genesis Capital Advisors
Genesis Capital Advisors
Similar Investor Metalmark Capital
Metalmark Capital
Similar Investor Health Catalyst Capital
Health Catalyst Capital
Similar Investor Moelis Capital Partners LLC
Moelis Capital Partners LLC
angels partners Overview

Contact over 100,000 investors!

Built by serial entrepreneurs and ex-VCs, Angels Partners helps entrepreneurs connect with relevant investors in their industry.

With over 100K+ listed investors, our mission is to help founders secure meetings & accelerate their fundraising.

View previous deals, filter by deal size, industry, location and more. It's the fastest way to build a target investor list.

e We also built a community of hundreds of investors actively prospecting & investing directly on Angels Partners.

 

Register to become visible to a large community of investors on our platform.

  • Sign up
  • Log in
  • Prime Founders
  • 85 Great Portland St.
  • London, U.K.
  •   contact@angelspartners.com
  • About Us
  • Terms & Conditions
  • Privacy Policy
  • Editorial Process
  • Contact Us
Copyright © 2024 - All trademarks and copyrights belong to their respective owners.
proof notifcation
32 New StartupsStarted their fundraisingover the last 7 daysproof logo